| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 637,000 | 624,600 | 596,400 | 634,200 | | Cost of Revenue | 240,900 | 238,600 | 224,300 | 243,500 | | | Gross Profit | 396,100 | 386,000 | 372,100 | 390,700 | | | Operating Expenses | | Research Development | 43,000 | 41,700 | 36,400 | 40,000 | | Selling General and Administrative | 164,300 | 160,600 | 173,600 | 179,200 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 188,800 | 183,700 | 162,100 | 171,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (600) | (16,900) |
-
| (2,700) | | Earnings Before Interest And Taxes | 188,200 | 166,800 | 162,100 | 168,800 | | Interest Expense | 3,000 | 3,000 | 3,000 | 3,000 | | Income Before Tax | 185,200 | 163,800 | 159,100 | 165,800 | | Income Tax Expense | 55,200 | 51,400 | 45,900 | 16,400 | | Minority Interest | 900 | (900) |
-
|
-
| | | | Net Income From Continuing Ops | 130,900 | 111,500 | 113,200 | 149,400 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 130,900 | 111,500 | 113,200 | 149,400 | | Preferred Stock And Other Adjustments | (1,400) | 700 | (700) |
-
| | | Net Income Applicable To Common Shares | $129,500 | $112,200 | $112,500 | $149,400 |
|
0.16% Nasdaq 0.00%
Income Statement
